Statistics

Total Visits

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies92

Select a period of time:

Number of views in the range

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies20

Views

Views
September 202511
October 20253
November 20252
December 20250
January 20261
February 20260
March 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil3
United Kingdom2
Argentina1
Ecuador1
Spain1
Mexico1
Paraguay1
 

Top cities views

Views
Dallas5
São Paulo2
Ambato1
Encarnación1
Gustavo Adolfo Madero1
Hurlingham1
Mountain Top1
Teresina1